Targeted Medical Pharma Inc  

(Public, OTCMKTS:TRGM)   Watch this stock  
Find more results for J Gintz
0.750
0.000 (0.00%)
Delayed:   10:12AM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.75 - 0.75
52 week 0.49 - 5.10
Open 0.75
Vol / Avg. 200.00/9,230.00
Mkt cap 19.75M
P/E     -
Div/yield     -
EPS -0.61
Shares 26.33M
Beta     -
Inst. own 0%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -78.50% -131.38%
Operating margin -68.57% -84.15%
EBITD margin - -78.18%
Return on average assets -138.22% -97.79%
Return on average equity - -
Employees 65 -
CDP Score - -

Address

Suite 301 2980 Beverly Glen Circle
LOS ANGELES, CA 90077
United States - Map
+1-310-4749809 (Phone)
+1-310-5317089 (Fax)

Website links

Description

Targeted Medical Pharma Inc. is a pharmaceutical company. The Company develops and commercializes nutrient- and pharmaceutical-based therapeutic systems. The Company also does business as Laboratory Industry Services (LIS), which is a facility for the performance of diagnostic testing. The Company´┐Żs operates in two business segments: Targeted Medical Pharma Inc (TMP) and Complete Claims Processing, Inc. (CCPI). The Company's therapeutic products focus on multiple diseases and disorders that consist of patient populations. As of December 31, 2010, it offered nine medical food products that can be used as a standalone therapy or co-administered with the lowest food and drug administration (FDA) approved dose of generic pharmaceuticals as part of a therapeutic system for the dietary management of disease.

Officers and directors

David Samuel Silver M.D. President, Chief Operating Officer, Director
Age: 47
William E. Shell M.D. Chief Executive Officer, Chief Scientific Officer, Director
Age: 70
William B. Horne Chief Financial Officer
Age: 42
Kim Giffoni Executive Vice President - Foreign Sales and Investor Relations, Director
Age: 61
Douglas Gintz Chief Technology and Information Officer
Amir R. Blachman Chief Compliance and Ethics Officer, Vice President - Operations and Strategy, Corporate Secretary
Age: 41
Maurice J. DeWald Non-Executive Independent Chairman of the Board
Age: 73
Thomas Wenkart Director
Arthur R. Nemiroff Independent Director
Age: 70
Donald J. Webster Independent Director
Age: 58